Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Iradimed (IRMD) Leases (2019 - 2025)

Iradimed has reported Leases over the past 7 years, most recently at $59221.0 for Q1 2025.

  • Quarterly Leases fell 96.94% to $59221.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $59221.0 through Mar 2025, down 96.94% year-over-year, with the annual reading at $154688.0 for FY2024, 92.43% down from the prior year.
  • Leases was $59221.0 for Q1 2025 at Iradimed, down from $154688.0 in the prior quarter.
  • Over five years, Leases peaked at $2.7 million in Q1 2021 and troughed at $59221.0 in Q1 2025.
  • The 5-year median for Leases is $2.2 million (2023), against an average of $1.8 million.
  • Year-over-year, Leases fell 2.76% in 2023 and then tumbled 96.94% in 2025.
  • A 5-year view of Leases shows it stood at $2.5 million in 2021, then fell by 11.15% to $2.2 million in 2022, then decreased by 7.36% to $2.0 million in 2023, then plummeted by 92.43% to $154688.0 in 2024, then crashed by 61.72% to $59221.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Leases are $59221.0 (Q1 2025), $154688.0 (Q4 2024), and $264075.0 (Q3 2024).